Picture of Sinopharm logo

1099 — Sinopharm News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Brief: Sinopharm Group Says HY Revenue RMB300.95 Bln

Aug 28 (Reuters) - Sinopharm Group Co Ltd  1099.HK :
    * HY REVENUE RMB300.95 BILLION VERSUS RMB261.5 BILLION
    * HY PROFIT ATTRIBUTABLE RMB4.10 BILLION VERSUS RMB3.69
BILLION
    * NO INTERIM DIVIDEND WAS PROPOSED FOR SIX-MONTH PERIOD
ENDED 30
JUNE 2023

Source text for Eikon:  ID:nHKS3Qvpdk 
Further company coverage:  1099.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sinopharm

See all news